Markets

Market Nav

News Details

03/11/2025 17:21

Jagsonpal Pharma - Board Meeting Outcome for Outcome Of Board Meeting

Pursuant to Regulation 30 & Regulation 33 of SEBI (LODR) Regulations, 2015, we would like to inform you\r\nthat the Board of Directors at its Meeting held today, inter-alia, considered and approved the Unaudited Financial\r\nResults for the quarter and half year ended September 30, 2025. \r\nkindly find enclosed the Unaudited Financial Results along with its Limited Review Report issued by the Statutory Auditors of the Company for the quarter and half year ended September 30, 2025.